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A series of 3-methyl-4-((3-aryl-1-phenyl-1H-pyrazol-4-yl)methylene)isoxazol-5(4H)-one derivatives have been 
efficiently synthesized by environmentally benign, one-pot three component condensation of substituted 1,3-diaryl-1H-
pyrazole-4-carboxyaldehyde, β-keto ester and hydroxyl amine hydrochloride in the presence of ionic liquid [HNMP][HSO4] 
as a catalyst in ethanol. These derivatives have been synthesized by conventional, ultrasound and microwave irradiation 
methods. The combination of ionic liquid with ultrasound as well as microwave irradiation makes the protocol fascinating 
and environmentally benign. In addition, it has several benefits such as simple work-up procedure, clean reaction profile, 
short reaction time and good yields. 
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Recently ionic liquids (ILs) have grown interest in 
diverse areas of chemistry; because of considerable 
interest as eco-friendly reaction solvent and catalyst in 
the organic synthesis. They exhibit significant 
properties such as negligible vapor pressure, broad 
liquid range, non-flammability, adequate ionic 
conductivity, potentially recyclable properties and 
capacity to dissolve a variety of organic and inorganic 
solids. Acidic ionic liquids have been employed in 
divergent areas due to their fascinated physical and 
chemical properties. [HNMP][HSO4] is also a 
brønsted acidic ILs has successfully used in various 
organic reactions such as cyclocondensations 
reactions, Oxa-Michael addition, Prins reaction and 
trans-esterification reactions1-6. 
Literature survey revealed that, the isoxazol-5(4H)-
ones and their derivatives have vital importance in 
divergent areas such as organic synthesis, liquid 
crystalline materials, filter dyes in photographic films, 
light-conversion molecular devices, optical storage 
and nonlinear optical research7-11. The isoxazol-
5(4H)-ones scaffold bearing both nitrogen and oxygen 
atoms are an important class of five member 
heterocycles, which display good pharmaceutical and 
biological activities12, 13. It is considered a major core 
in the discovery of protein kinase inhibitors, which is 
playing an important role in the growth of 
chemotherapeutic agents14, 15. They also show 
significant analgesic, antibacterial, anti-HIV, 
antifungal, anti-inflammatory, anti-mycobacterial, 
anticancer, antioxidant, antitumor, antiprotozoal, anti-
tubercular, nematicidal and antiviral activities16-28. 
The some important illustrations of isoxazol-5(4H)-
one nucleus containing agents are shown in Figure 1. 
Several protocols have been studied in the 
literature for the synthesis of isoxazol-5(4H)-one and 
their analogues. Among them some illustrations are 
N-bromosuccinimide (NBS)29, Ag/SiO230, 
phthalimide-N-oxyl salts (POPINO and TBAPINO)31, 
NaOAc/visible light32, boric acid33, catalyst free34, 
citric acid35, NaH2PO436, pyridine/reflux37, sodium 
benzoate38, sodium saccharin39, pyridine/US40, 
pottasium phthalimide41, sodium sulfide42, 
H3PW12O40, clinoptilolite, nano Fe2O343, etc. 
Ultrasound (US) and Microwave (MW) assisted 
transformations are well established class of synthetic 
organic chemistry. The significant benefit of MW and 
US irradiated organic synthesis is of rapidly synthesize 
library of organic compounds with improved yields 
and selectivities. The MW and US assisted 
multicomponent reaction with various green catalysts 
such as ionic liquids, nano-particles, vitamins and 
zeolites etc. makes protocol more interesting, 
fascinating and environmentally benign44-54. 
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In view of biologial importance of isoxazolone 
nuclues as well as green approach of ILs in the 
multicomponent reaction and continution of our work 
in this field55-59; we have described the synthesis of 
isoxazolone derivatives by multi-component 
condensation of substituted 1,3-diphenyl-1H-
pyrazole-4-carboxyaldehyde (1), β-keto ester (2), 
hydroxylamine hydrochloride (3) and 100 mg of N-
Methyl-2-Pyrrolidonium Hydrogen Sulphate 
[HNMP][HSO4].  
 
Results and Discussion 
Initially, we examined the model reaction between 
1-phenyl-3-p-tolyl-1H-pyrazole-4-carbaldehyde 1a, 
ethyl acetoacetate 2, hydroxyl amine hydrochloride 3 
under different conditions. A literature study of 
solvents indicated that ethanol is the most suitable 
reaction medium for the synthesis of isoxazolone 
derivatives. When the reaction was conducted at room 
temperature with constant stirring, reaction did not 
proceed with and without catalyst. The reaction 
proceeds with good results under reflux condition. 
Additional experimental study revealed that the 
required catalyst amount was found to be 100 mg for 
better yield (Entry 7). The results obtained during 
optimization are summarized in Table I. 
For comparison, reactions were also carried out 
under US and MW conditions. As expected, USI 
(Entry 10) and MWI (Entry 12) assisted synthesis 
required shorter reaction time and higher yield as 
compared to conventional heating. 
After the determination of the optimized conditions, 
we twisted our consideration in the direction of studying 
the scope of the method. The isoxazolone derivatives 
with both electron-donating and electron-withdrawing 
substituent on the aromatic ring were tolerated and 
afforded high yields (Table II). 
 
Experimental Section 
The physical constants were recorded in an open 
capillary and are uncorrected. IR spectra were 
recorded on a Perkin-Elmer FTIR spectrophotometer. 
The 1H NMR spectrums were recorded on a Brucker 
Avance II 400MHz in DMSO
 
and 13C NMR was 
recorded on 100MHz in DMSO. Mass spectra were 
recorded on a Finnigan Mass spectrometer. TLC was 
carried out on pre-coated silica gel Al-plates to check 
the purity of the compounds. 
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Figure 1 — Isoxazol-5(4H)-ones nucleus containing drugs 
 
Table I — Optimization of reaction condition to synthesize isoxazolone derivative 4a 
Entry Catalyst/ Solvent Reaction Condition Time Yield (%) 
1 No catalyst/ Solvent free Stirring at RT 2 h NR 
2 No catalyst/ EtOH Stirring at RT 2 h NR 
3 100 mg [HNMP][HSO4]/ SF Stirring at RT 2 h NR 
4 100 mg [HNMP][HSO4]/ EtOH Stirring at RT 2 h NR 
5 50 mg [HNMP][HSO4]/ EtOH Reflux 4 h 25 
6 75 mg [HNMP][HSO4]/ EtOH Reflux 4 h 64 
7 100 mg [HNMP][HSO4]/ EtOH Reflux 4 h 70 
8 125 mg [HNMP][HSO4]/ EtOH Reflux 4 h 72 
9 100 mg [HNMP][HSO4]/ EtOH USI at RT 30 min Trace 
10 100 mg [HNMP][HSO4]/ EtOH USI at 45oC 30 min 80 
11 100 mg [HNMP][HSO4]/ EtOH MWI at 140 W 10 min 15 
12 100 mg [HNMP][HSO4]/ EtOH MWI at 210 W 5 min 82 
Reaction Conditions: 1-phenyl-3-p-tolyl-1H-pyrazole-4-carbaldehyde 1a (1 mmol), Ethyl acetoacetate 2 (1 mmol), hydroxyl amine 
hydrochloride 3 (1 mmol) and 50-125 mg [HNMP][HSO4] 
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The precursor 1,3-diaryl-1H-pyrazole-4-
carboxyaldehyde were synthesized by Vilsmeier 
Haack formylation reaction60, whereas the catalyat 
[HNMP][HSO4] was prepared and purified as 
reported by B. M. Bhanage and co-authors4. 
 
General Procedure for the Synthesis of 
Isoxazolone derivatives 4(a-k) Under Conventional 
Reflux Condition  
A mixture equimolar quantities of 1,3-diaryl-1H-
pyrazole-4-carboxyaldehyde 1 (1 mmol), β-keto ester 
2 (1 mmol), hydroxyl amine hydrochloride 3 (1 
mmol) and 100 mg of [HNMP][HSO4] was placed in 
a 100 mL round bottom flask containing 10 mL of 
EtOH. Then the reaction mixture was refluxed for 
appropriate time. The progress of the reaction was 
monitored by TLC. After completion of the reaction, 
the content were cooled to room temperature, solid 
product thus obtained was separated by filtration. The 
crude product was washed by cold ethanol to get pure 
product (Scheme I). 
 
Under Ultra Sound Irradiation  
A mixture equimolar quantities of substituted 1,3-
diphenyl-1H-pyrazole-4-carbaldehyde 1 (1 mmol),  
β-keto ester 2 (1 mmol), hydroxyl amine 
hydrochloride 3 (1 mmol) and 100 mg of Ionic liquid 
[HNMP][HSO4] was taken in a 100 mL round bottom 
flask containing 10 mL of EtOH. The reaction 
mixture was placed for US irradiation at 45oC for 
appropriate time. The progress of the reaction was 
monitored by TLC. After completion of the reaction, 
Table II — Synthesis of isoxazolone derivatives 4a-k using [HNMP][HSO4] as a catalyst 
Entry Ar- 
Group 
R- 
Group 
Reaction Time (min.) Yield (%) m.p. in (oC)  
Reflux US MW Reflux US MW 
4a 
H3C
 
-CH3 240 30 5 70 80 82 210 
4b 
H
 
-CH3 240 28 4 71 80 81 208 
4c 
F
 
-CH3 270 34 6 68 78 80 204 
4d 
Cl
 
-CH3 240 30 4 74 82 82 228 
4e 
Br
 
-CH3 240 30 5 72 80 80 234 
4f 
O2N
 
-CH3 270 32 6 68 75 75 268 
4g 
S
 
-CH3 240 28 4 74 82 84 192 
4h 
F
O2N
 
-CH3 300 32 6 68 76 78 196 
4i 
F
Br
 
-CH3 300 30 6 70 80 82 226 
4j 
F
F
 
-CH3 300 32 5 72 78 83 224 
4k 
H3C
 
-CF3 240 30 4 72 80 80 160 
Reaction Condition- Substituted 1,3-diphenyl-1H-pyrazole-4-carbaldehyde 1 (1 mmol), Ethyl acetoacetate 2 (1 mmol), hydroxyl amine 
hydrochloride 3 (1 mmol), 100 mg [HNMP][HSO4] and 10 mL ethanol. 
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the content were cooled to room temperature, solid 
product thus obtained was separated by filtration. The 
crude product was washed with cold ethanol to get 
pure product (Scheme I). 
 
Under Microwave Irradiation 
A mixture equimolar quantities of substituted 1, 
3-diphenyl-1H-pyrazole-4-carbaldehyde 1 (1mmol), 
β-keto ester 2 (1 mmol), hydroxyl amine 
hydrochloride 3 (1mmol) and 100 mg of Ionic liquid 
[HNMP][HSO4] was taken in a 100 mL round bottom 
flask containing 10 mL of EtOH. The reaction 
mixture was subjected for MW irradiation at level 2 
(210 W) for appropriate time. The progress of the 
reaction was monitored by TLC. After completion of 
the reaction, the content were cooled to room 
temperature, solid product thus obtained was 
separated by filtration. The crude product was washed 
with cold ethanol to get pure product (Scheme I). 
 
Spectral Data of Synthesized Compounds 
3-methyl-4-((1-phenyl-3-p-tolyl-1H-pyrazol-4-
yl) methylene)isoxazol-5(4H)-one, 4a: Pale Yellow 
Solid; m.p. 210ºC; FT-IR (KBr) ν: 3145, 2980, 1735, 
1612, 1599, 1532, 1507, 1454, 1231, 1122, 996, 873, 
757; 1H NMR (DMSO-d6, 400 MHz): δ 2.24 (s, 3H, -
CH3), 2.42 (s, 3H, -CH3), 7.41 (d, 2H, Ar-H), 7.49 (t, 
1H, Ar-H), 7.61-7.68 (m, 5H, Ar-H), 7.92 (s, 1H, 
Pyrazole ring-H), 7.94 (d, 1H, Ar-H), 9.87 (s, 1H, 
vinylic proton); 13C NMR (DMSO-d6, 100 MHz): δ 
10.89, 20.89, 114.73, 115.09. 116.62, 127.61, 128.24, 
129.11, 129.66, 129.97, 133.48, 138.37, 139.18, 
139.95, 149.25, 161.70, 168.93; MS: m/z = 344.39 
[M+1]+. 
 
3-methyl-4-((1,3-diphenyl-1H-pyrazol-4-yl) methyle 
ne)isoxazol-5(4H)-one, 4b: Pale Yellow Solid; m.p. 
208ºC; FT-IR (KBr) ν: 3148, 3057, 2982, 1735, 1613, 
1599, 1517, 1502, 1447, 1335, 1222, 1128, 994, 872, 
704; 1H NMR (CDCl3, 400 MHz): δ 2.24 (s, 3H, -
CH3), 7.44 (t, 1H, Ar-H), 7.52-7.61 (m, 6H, Ar-H), 
7.67 (m, 2H, Ar-H), 7.92 (m, 2H, Ar-H and Pyrazole 
ring-H), 10.03 (s, 1H, vinylic proton); MS: m/z = 
330.53 [M+1]+. 
 
4-((3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)m 
ethylene)-3-methylisoxazol-5(4H)-one, 4c: Pale 
Yellow Solid; m.p. 204ºC; 1H NMR (CDCl3, 400 
MHz): δ 2.243 (s, 3H, -CH3), 7.29 (t, 2H, Ar-H), 7.44 
(t, 2H, Ar-H), 7.49-7.69 (m, 4H, Ar-H), 7.90 (m, 2H, 
Ar-H and Pyrazole ring-H), 10.01 (s, 1H, vinylic 
proton); MS: m/z = 348.34 [M+1]+. 
 
4-((3-(4-chlorophenyl)-1-phenyl-1H-pyrazol-4-yl)m 
ethylene)-3-methylisoxazol-5(4H)-one, 4d: Pale 
Yellow Solid; m.p. 228ºC; 1H NMR (DMSO-d6, 400 
MHz): δ 2.31 (s, 3H, -CH3), 7.26 (t, 2H, Ar-H), 7.42-
7.45 (m, 2H, Ar-H), 7.53-7.57 (m, 5H, Ar-H), 7.89 (s, 
N
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Scheme I — Synthesis of isoxazolone derivatives 
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1H, Pyrazole ring-H), 9.98 (s, 1H, vinylic proton); 
MS: m/z = 364.27 [M+1]+. 
 
4-((3-(4-bromophenyl)-1-phenyl-1H-pyrazol-4-
yl)methylene)-3-methylisoxazol-5(4H)-one, 4e: Pale 
Yellow Solid; m.p. 234ºC; 1H NMR (CDCl3, 400 
MHz): δ 2.25 (s, 3H, -CH3), 7.46 (t, 2H, Ar-H), 7.55 
(m, 4H, Ar-H), 7.72 (m, 2H, Ar-H), 7.89 (m, 2H, Ar-
H and Pyrazole ring-H), 10.04 (s, 1H, vinylic proton). 
 
3-methyl-4-((3-(4-nitrophenyl)-1-phenyl-1H-pyraz 
ol-4-yl)methylene)isoxazol-5(4H)-one, 4f: Pale 
Yellow Solid; m.p. 268ºC; 1H NMR (DMSO-d6, 400 
MHz): δ 2.27 (s, 3H, -CH3), 7.47 (t, 2H, Ar-H), 7.49-
7.56 (m, 3H, Ar-H), 7.78 (dd, J = 4.0 Hz, 2H, Ar-H), 
8.04 (s, 1H, Pyrazole ring-H), 8.26 (dd, J = 4.0 Hz, 
2H, Ar-H), 9.97 (s, 1H, vinylic proton); MS: m/z = 
375.19 [M+1]+.  
 
3-methyl-4-((1-phenyl-3-(thiophen-2-yl)-1H-pyraz 
ol-4-yl)methylene)isoxazol-5(4H)-one, 4g: Pale 
Yellow Solid; m.p. 192ºC; FT-IR (KBr) ν: 3145, 
3109, 2982, 1744, 1613, 1530, 1498, 1460, 1221, 
1128; 1H NMR (DMSO-d6, 400 MHz): δ 2.31 (s, 3H, 
-CH3), 7.28 (m, 1H, Ar-H), 7.48 (m, 1H, Ar-H), 7.61 
(m, 2H, Ar-H), 7.68 (m, 1H, Ar-H), 7.77 (m, 1H, Ar-
H), 7.81 (s, 1H, Pyrazole ring-H), 7.88 (m, 2H, Ar-H), 
9.86 (s, 1H, vinylic proton); 13C NMR (DMSO-d6, 
100 MHz): δ 10.94, 114.85, 115.24. 119.41, 128.17, 
128.39, 128.46, 128.70, 129.80, 131.84, 133.53, 
138.10, 138.66, 150.33, 161.42, 168.79; MS: m/z = 
336.35 [M+1]+. 
 
4-((3-(4-fluoro-3-nitrophenyl)-1-phenyl-1H-pyrazo l-
4-yl)methylene)-3-methylisoxazol-5(4H)-one, 4h: 
Pale Yellow Solid; m.p. 196ºC; 1H NMR (DMSO-d6, 
400 MHz): δ 2.28 (s, 3H, -CH3), 7.40 (s, 1H, Ar-H), 
7.47 (t, 1H, Ar-H), 7.53-7.59 (m, 3H, Ar-H), 7.89 (d, 
J = 4.0 Hz, 2H, Ar-H), 8.00 (s, 1H, Pyrazole ring-H), 
8.39 (dd, J = 4.0 Hz, 1H, Ar-H), 10.03 (s, 1H, 
vinylic proton). 
 
4-((3-(3-bromo-4-fluorophenyl)-1-phenyl-1H-pyra 
zol-4-yl)methylene)-3-methylisoxazol-5(4H)-one, 4i: 
Pale Yellow Solid; m.p. 226ºC; 1H NMR (CDCl3, 
400 MHz): δ 2.26 (s, 3H, -CH3), 7.34 (t, 1H, Ar-H), 
7.40 (d, 1H, Ar-H), 7.46 (t, 1H, Ar-H), 7.57 (m, 3H, 
Ar-H), 7.90 (m, 3H, Ar-H and Pyrazole ring-H), 
10.00 (s, 1H, vinylic proton). 
 
4-((3-(3,5-difluorophenyl)-1-phenyl-1H-pyrazol-4-yl) meth- 
ylene)-3-methylisoxazol-5(4H)-one, 4j: Pale Yellow Solid; 
m.p. 224ºC; FT-IR (KBr) ν: 3148, 3077, 2977, 1729, 1605, 1505, 
1434, 1338, 1229, 1125, 992, 860, 794; 1H NMR (CDCl3, 400 
MHz) δ: 2.28 (s, 3H, -CH3), 7.02 (m, 1H, Ar-H), 7.21 (m, 2H, Ar-
H), 7.46 (m, 2H, Ar-H), 7.57 (t, 2H, Ar-H), 7.89 (m, 2H, Ar-H 
and Pyrazole ring-H), 10.01 (s, 1H, vinylic proton); MS: m/z = 
366.30 [M+1]+. 
 
Conclusion 
We have developed a green protocol for the one-pot 
synthesis of isoxazolone derivatives using [HNMP][HSO4] as 
an efficient catalyst. The series of isoxazolone 4(a-k) 
derivatives was synthesized from various 1,3-diaryl-1H-
pyrazole-4-carboxyaldehyde, aceto-acetic ester and hydroxyl 
amine hydrochloride in ethanol by conventional reflux 
condition, US, and MW irradiation for suitable time. It was 
found that, the US and MW assisted reaction in 
[HNMP][HSO4] provides several benefits as compared with 
the conventional method. This fascinating US and MW 
assisted protocol was offered the simple work-up procedure, 
short reaction time, excellent yield with the environmentally 
benign approach and a significant contribution in green 
technology. 
 
Supplementary Information 
Supplementary information is available in the 
website http://nopr.niscair.res.in/handle/123456789/60. 
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